Published in Vopr Virusol on May 15, 2007
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis (1993) 1.69
Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis (1999) 1.49
Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine (1999) 1.43
Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis (2011) 1.36
Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia. Epidemiol Infect (2009) 1.36
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis (1998) 1.28
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine (2006) 1.16
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine (2000) 1.06
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol (1995) 1.04
Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. Clin Vaccine Immunol (2011) 0.99
Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains. J Gen Virol (1981) 0.98
Biochemical and serological studies of influenza B viruses: comparisons of historical and recent isolates. Virus Res (1984) 0.95
Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infect Immun (1984) 0.94
[Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus]. Vopr Virusol (1977) 0.94
Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect Immun (1984) 0.93
Testing the safety and effectiveness of oral administration of a live influenza vaccine. Bull World Health Organ (1970) 0.91
[Isolation of temperature-sensitive strains of the influenza virus in the epidemic caused by the A/Victoria virus in 1975-1976]. Vopr Virusol (1979) 0.91
Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds. Bull World Health Organ (1996) 0.90
[Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination]. Vopr Onkol (1996) 0.89
Conditions for production of thermosensitive attenuated influenza virus recombinants. Acta Virol (1978) 0.87
Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle. Acta Virol (1980) 0.86
Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus. Acta Virol (1982) 0.86
[Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses]. Vopr Virusol (1998) 0.85
[Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. Mol Gen Mikrobiol Virusol (2011) 0.84
Pathogenicity of cryophilic and thermophilic strains of influenza type A2 virus for developing chick embryos and albino mice. Acta Virol (1969) 0.84
[Experience in selecting safe heat-sensitive influenza virus A recombinants]. Vopr Virusol (1979) 0.84
Genome analysis of H1N1 influenza virus strains isolated in the U.S.S.R. during an epidemic in 1961-1962. Arch Virol (1981) 0.82
[The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants]. Vopr Virusol (1995) 0.82
[Effect of the times of remantadine administration on its content in MDCK cells and white mouse lung tissues infected and uninfected with the influenza virus]. Vopr Virusol (1982) 0.82
[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol (1994) 0.81
[Effect of impulse-intermittent ultrahigh frequency irradiation on synthesis of nucleic acids in tumor cells]. Radiats Biol Radioecol (2005) 0.80
[Restriction analysis of genome composition of live influenza vaccine]. Vopr Virusol (2011) 0.80
Analysis of the genome of influenza A virus strains (H3N2) isolated during the epidemic season of 1982-1983. Arch Virol (1985) 0.79
Temperature-sensitive recombinants of influenzavirus B. Acta Virol (1978) 0.79
[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009]. Vopr Virusol (2013) 0.79
Studies on a temperature-sensitive mutant of fowl plague virus having a mutation in gene 7 coding for the M protein. J Gen Virol (1983) 0.79
[Phenotyte of epidemic influenza B virus strains isolated in different years]. Vopr Virusol (2006) 0.78
[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.78
Effects of edeine, hygromycin B and alpha-Sarcin on influenza virus reproduction. Acta Virol (1981) 0.78
Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain. Acta Virol (1983) 0.78
[Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.78
[The effect of amplifying reproduction of influenza virus in mouse lungs during simultaneous infection with two cold-adapted strains]. Vopr Virusol (1990) 0.78
[The reactive and immunogenic properties and epidemiological effectiveness of further attenuated influenza virus vaccinal strains (observed in preschool children)]. Vopr Virusol (1966) 0.78
Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005. Arch Virol (2006) 0.78
[PCR restriction analysis of the genome composition of reassortant cold-adapted influenza B virus strains]. Vopr Virusol (2007) 0.78
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine (1993) 0.77
[Results in the study of a special live influenza vaccine variant for the immunization of preschool and young school-age children]. Vestn Akad Med Nauk SSSR (1968) 0.77
[Different receptor specificity of influence viruses from ducks and chickens and its reflection in the composition of sialosides on host cells and mucins]. Vopr Virusol (2006) 0.77
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine]. Vopr Virusol (2012) 0.77
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Vopr Virusol (2002) 0.77
[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.77
Studies of a recombinant which inherited the haemagglutinin from the human influenza virus A/Hong Kong/1/68 (H3n2) and other genes from influenza virus A/duck/Ukraine/1/63 (H3N8). J Gen Virol (1984) 0.77
[Epidemiologic effectiveness of live enteral adenovirus and influenza vaccine on susceptible groups of adults]. Vestn Akad Med Nauk SSSR (1968) 0.77
[Effect of Point Mutations in the Polymerase Genes of the Influenza A/PR/8/34 (H1N1) Virus on the Immune Response in a Mouse Model]. Vopr Virusol (2015) 0.77
The variability of genes of influenza A (H3N2) virus strains isolated in the G.D.R. during the 1970-1978 epidemic seasons. Acta Virol (1985) 0.76
Interfering activity of virulent and attenuated influenza virus strains. Acta Virol (1976) 0.76
Studies of fowl plague virus temperature-sensitive mutants with defects in transcription. J Gen Virol (1982) 0.76
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates. Vaccine (1990) 0.76
[Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57]. Vopr Virusol (1986) 0.76
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76
[Factors that cause a change in the antigenic structure of of the influenza virus hemagglutinin]. Vopr Virusol (1993) 0.75
[Criteria of primary screening of attenuated strains for live vaccine against Influenza A]. Vopr Virusol (2001) 0.75
[Results and prospects for vaccinal prevention of influenza]. Vopr Virusol (1977) 0.75
[Use of "split" courses of combination chemotherapy in breast cancer]. Vopr Onkol (1981) 0.75
Partial change of the ts-phenotype of cold-adapted influenza virus strain grown in canine kidney cells in the presence of trypsin. Acta Virol (1982) 0.75
[Lymphangiosarcoma of the upper extremity after mastectomy for cancer]. Vestn Khir Im I I Grek (1981) 0.75
Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination. Acta Virol (1980) 0.75
[Differentiating markers of virulent and attenuated (cold-adapted) strains of influenza A virus]. Vopr Virusol (1977) 0.75
Correlation between reproductive and interfering activities of epidemic and thermosensitive influenza virus strains. Acta Virol (1982) 0.75
[The biological properties of 2 strains of adenovirus serotype 4]. Vopr Virusol (1972) 0.75
[Study of the biology of intratype variants of adenovirus serotypes 1, 2, 3, 4 and 7]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Basis of the anthroponotic nature of human pandemic influenza A viruses]. Vopr Virusol (1981) 0.75
[Comparative characteristics of reactogenic and immunogenic properties of the attenuated live influenza vaccine in intranasal and peroral administration in children]. Pediatriia (1969) 0.75
[Homologous and heterologous antibody induction in influenzal infection and immunization]. Vopr Virusol (1977) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
[Effect of non-specific inhibitors in horse serum on human adenoviruses]. Vopr Virusol (1972) 0.75
[Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine]. Tr Inst Im Pastera (1976) 0.75
[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Vopr Virusol (2005) 0.75
[Antitumor activity of cold-adapted strains of influenza virus in a model transformed murine tumor cells]. Vopr Virusol (1999) 0.75
[Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome]. Vopr Virusol (1995) 0.75
[Dynamics of adenovirus reproduction in the liver of newborn hamsters and changes in humoral immunity factors in experimental adenovirus hepatitis]. Vopr Virusol (1972) 0.75